Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Separation of Benign and Malignant Mesothelial Proliferations

20 Aug 2020

Abstract excerpt

The separation of benign from malignant mesothelial proliferations is an important clinical but often a difficult morphologic problem. Over the last roughly 10 years a variety of new markers that aid in this separation have been published and some older recommended markers reconsidered. Unlike previous, and largely unusable, empiric immunohistochemical (IHC) stains, these new markers, some using IHC and some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Medical Imaging and Pathology Studies
Share to Occupational and environmental lung diseases
Share to Pleural and Pulmonary Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32826526
DOI: 10.1097/pas.0000000000001565

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Separation of Benign and Malignant Mesothelial ProliferationsPMID 32826526Read ↗

New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?Semantic proximity Read ↗

Malignant mesothelioma in situ: diagnostic and clinical considerations.Semantic proximity Read ↗

Progression of Sarcomatoid Mesothelioma from Mesothelioma In Situ: A Case Report on Morphologic Changes during a Nine-month Interval and Careful Observation of Cytology in Early- stage MesotheliomaSemantic proximity Read ↗

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions.Semantic proximity Read ↗

Novel insights into mesothelioma biology and implications for therapySemantic proximity Read ↗

Genomics and Epigenetics of Malignant MesotheliomaSemantic proximity Read ↗

FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesotheliomaSemantic proximity Read ↗

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.Semantic proximity Read ↗

The cytologic criteria of malignancySemantic proximity Read ↗

Validation of a Gene-Expression Approach for the Cytological Diagnosis of Epithelioid and Biphasic Pleural Mesothelioma on a Consecutive SeriesSemantic proximity Read ↗

A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural MesotheliomasSemantic proximity Read ↗

Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.